SEC Form 4 · accession 0001171843-17-000509
Xenon Pharmaceuticals Inc. · XENE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael M Tarnow
Director
Period of report
Jan 26, 2017
Accepted (ET)
Jan 27, 2017 · 5:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001582313
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Jan 26, 2017 | G | 7,201 | $0.00 | D | 55,167 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were gifted to family members that do not share the reporting person's household.